Company / SG&A per Share
Bone Biologics Corp SG&A per Share History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.04
FY2020
5-year range
$0.04 / $0.91
FY2017-FY2020
Trend
-56.6%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.91 to $0.04 over the past 2 years.
Based on SEC 10-K filings.
0.04 in FY2020 with a 3-year CAGR of -35.7%.
Improved from $0.91 to $0.04 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -35.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, sg&a per share decreased 56.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $0.04 | -56.6% |
| FY2019 | $0.10 | -88.9% |
| FY2018 | $0.91 | +450.7% |
| FY2017 | $0.17 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026